Corporate Social Responsibility | Alnylam® Newsroom

Global English
- AustriaDeutsch
- BelgiumNederlands Français
- BrazilPortuguês
- CanadaFrançais English
- Czech RepublicČeština
- DenmarkDansk
- FranceFrançais
- GermanyDeutsch
- IrelandEnglish
- ItalyItaliano
- Japan日本語
- LuxembourgFrançais Deutsch
- NetherlandsNederlands
- PortugalPortuguês
- SpainEspañol
- SwedenSvenska
- SwitzerlandFrançais Deutsch Italiano
- Taiwan繁體中文
- United KingdomEnglish

Corporate Social Responsibility

May 7, 2024 Alnylam Publishes 2023 Corporate Responsibility Report Alnylam's 2023 Corporate Responsibility Report details our corporate responsibility and ESG efforts and progress. Read More ›

April 25, 2024 Our Commitment to Patients Means Never Stop Evolving - Our Patient Access Philosophy Tolga Tanguler, Alnylam's Chief Commercial Officer discusses Alnylam's Patient Access Philosophy and approach to access Read More ›

Subscribe to Corporate Social Responsibility

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site